A recent study shows that combining meal replacement therapy with financial incentives led to a 6 percentage point greater reduction in BMI for adolescents with severe obesity compared to meal replacement therapy alone.

Early use of high-efficacy disease-modifying therapies in pediatric-onset MS patients with minimal disability reduces the risk of progression by 59% compared to no treatment.

Roflumilast cream 0.15% demonstrates rapid and significant improvement in itch within 24 hours of the first application, addressing a primary concern for atopic dermatitis patients.

CBD gummies offer a convenient administration method with prolonged effects, but their delayed onset presents unique considerations for therapeutic use. Understanding the pharmacokinetics and individual factors affecting CBD absorption is essential for optimizing patient outcomes.

Pityriasis alba presents unique diagnostic and management challenges, particularly in diverse patient populations. Understanding its clinical course and potential associations with other dermatological conditions is crucial for optimal patient care and education.

Oropharyngeal tularemia can mimic common bacterial pharyngitis, but its rarity and nonspecific symptoms make diagnosis challenging without a high index of suspicion.